UNSPSC 51202101: Diphtheria toxoid/pertussis vaccine/tetanus toxoid

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class IM100. This VA Drug Class (IM100) classifies this compound as belonging to the group VACCINES.

UNSPSC 51202101 Diphtheria toxoid/pertussis vaccine/tetanus toxoid is a Commodity code, but the recent state and local activity tracked under it covers immunization products beyond the nominal scope, including Yellow Fever Vaccine. State and local health departments solicit vaccines and immunization supplies through sole source notices, competitive RFPs, and other procurement vehicles when standard supply channels are unavailable or when single-source agreements drive formal purchasing processes. The issuing bodies are primarily state health departments and related public health agencies responsible for disease prevention and immunization programs.

The Mississippi State Department of Health posted a sole source notice on July 13, 2026, for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026. The notice did not specify quantity, contract term, estimated value, or pricing. Objections to the sole source designation require written submission demonstrating the availability of alternative suppliers; if substantiated objections are received, the department will either conduct a competitive bid process or appeal to the Mississippi Public Procurement Review Board. This represents the most recent documented activity under the code in the state and local space.